User menu

Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Bibliographic reference Ribrag, V. ; Tilly, H. ; Casasnovas, O. ; Bosly, André ; Bouabdallah, R. ; et. al. Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). In: European Journal of Cancer, Vol. 49, no. 4, p. 904-910 (2013)
Permanent URL http://hdl.handle.net/2078.1/124390